China National Medicines Corporation Statistics

Total Valuation

China National Medicines Corporation has a market cap or net worth of CNY 26.41 billion. The enterprise value is 20.62 billion.

Market Cap	26.41B
Enterprise Value	20.62B

Important Dates

The next estimated earnings date is Friday, March 21, 2025.

Earnings Date	Mar 21, 2025
Ex-Dividend Date	Jun 13, 2024

Share Statistics

China National Medicines Corporation has 754.50 million shares outstanding. The number of shares has increased by 0.00% in one year.

Current Share Class	n/a
Shares Outstanding	754.50M
Shares Change (YoY)	+0.00%
Shares Change (QoQ)	+0.03%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	15.70%
Float	324.11M

Valuation Ratios

The trailing PE ratio is 12.20 and the forward PE ratio is 10.95.

PE Ratio	12.20
Forward PE	10.95
PS Ratio	0.52
PB Ratio	1.59
P/TBV Ratio	n/a
P/FCF Ratio	17.15
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 8.26, with an EV/FCF ratio of 13.39.

EV / Earnings	9.53
EV / Sales	0.40
EV / EBITDA	8.26
EV / EBIT	8.96
EV / FCF	13.39

Financial Position

The company has a current ratio of 2.04, with a Debt / Equity ratio of 0.04.

Current Ratio	2.04
Quick Ratio	1.66
Debt / Equity	0.04
Debt / EBITDA	0.27
Debt / FCF	0.43
Interest Coverage	111.26

Financial Efficiency

Return on equity (ROE) is 13.20% and return on invested capital (ROIC) is 7.91%.

Return on Equity (ROE)	13.20%
Return on Assets (ROA)	4.36%
Return on Capital (ROIC)	7.91%
Revenue Per Employee	16.31M
Profits Per Employee	689,922
Employee Count	3,138
Asset Turnover	1.55
Inventory Turnover	9.91

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +23.95% in the last 52 weeks. The beta is 0.45, so China National Medicines Corporation's price volatility has been lower than the market average.

Beta (5Y)	0.45
52-Week Price Change	+23.95%
50-Day Moving Average	31.98
200-Day Moving Average	32.31
Relative Strength Index (RSI)	59.59
Average Volume (20 Days)	10,918,089

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, China National Medicines Corporation had revenue of CNY 51.19 billion and earned 2.16 billion in profits. Earnings per share was 2.87.

Revenue	51.19B
Gross Profit	3.83B
Operating Income	2.30B
Pretax Income	2.91B
Net Income	2.16B
EBITDA	2.41B
EBIT	2.30B
Earnings Per Share (EPS)	2.87

Full Income Statement

Balance Sheet

The company has 8.30 billion in cash and 664.61 million in debt, giving a net cash position of 7.63 billion or 10.12 per share.

Cash & Cash Equivalents	8.30B
Total Debt	664.61M
Net Cash	7.63B
Net Cash Per Share	10.12
Equity (Book Value)	18.46B
Book Value Per Share	22.01
Working Capital	15.15B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 1.69 billion and capital expenditures -147.92 million, giving a free cash flow of 1.54 billion.

Operating Cash Flow	1.69B
Capital Expenditures	-147.92M
Free Cash Flow	1.54B
FCF Per Share	2.04

Full Cash Flow Statement

Margins

Gross margin is 7.49%, with operating and profit margins of 4.49% and 4.23%.

Gross Margin	7.49%
Operating Margin	4.49%
Pretax Margin	5.69%
Profit Margin	4.23%
EBITDA Margin	4.70%
EBIT Margin	4.49%
FCF Margin	3.01%

Dividends & Yields

This stock pays an annual dividend of 0.85, which amounts to a dividend yield of 2.44%.

Dividend Per Share	0.85
Dividend Yield	2.44%
Dividend Growth (YoY)	9.21%
Years of Dividend Growth	2
Payout Ratio	34.70%
Buyback Yield	-0.00%
Shareholder Yield	2.44%
Earnings Yield	8.20%
FCF Yield	5.83%

Dividend Details

Stock Splits

The last stock split was on June 3, 2009. It was a forward split with a ratio of 2.

Last Split Date	Jun 3, 2009
Split Type	Forward
Split Ratio	2

Scores

China National Medicines Corporation has an Altman Z-Score of 3.68.

Altman Z-Score	3.68
Piotroski F-Score	n/a